A Systematic Review Comparing Mineral Trioxide Aggregate to Other Commercially Available Direct Pulp Capping Agents in Dogs
- Elijah
- 0
Very important pulp remedy (VPT) and direct pulp capping (DPC) are procedures repeatedly carried out in canine for the administration of acute tooth fractures and as a part of administration for traumatic malocclusions. The aim of this assessment is to use an evidence-based medication strategy to systematically assessment and consider the scientific literature evaluating the efficacy of mineral trioxide mixture (MTA) to different commercially out there supplies used for VPT within the everlasting enamel of canine.
The 9 research assembly inclusion standards had been reviewed and every research proof was labeled utilizing a grading system modified from the Oxford Centre for Proof-Primarily based Medication. For the research assembly inclusion standards, MTA constantly carried out as effectively or higher than different commercially out there merchandise when it comes to calcific barrier formation and biocompatibility.
This assessment discovered a scarcity of consistency between the research making a direct comparability of the outcomes unreliable. Future research would profit from the implementation of a typical scoring system for histology, equal and longer research period occasions and the correlation of histological and radiographic information.
Molybdenum Trioxide Quantum Dot-Encapsulated Nanogels for Virus Detection by Floor-Enhanced Raman Scattering on a 2D Substrate
Using nanogels (NGs) to modulate surface-enhanced Raman scattering (SERS) actions is launched as an progressive technique to deal with sure important points with SERS-based immunoassays. This contains the chemical deformation of SERS nanotags, in addition to their nonspecific interactions and efficient “hotspots” formation.
Herein, the polymeric cocoon and stimuli-responsive properties of NGs had been used to encapsulate SERS nanotags containing plasmonic molybdenum trioxide quantum dots (MoO3-QDs). The pH-controlled launch of the encapsulated nanotags and their subsequent localization by maleimide-functionalized magnetic nanoparticles facilitated the creation of “hotspots” areas with catalyzed SERS actions. This strategy resulted in growing a biosensing platform for the ultrasensitive immunoassays of hepatitis E virus (HEV) or norovirus (NoV).
The immunoassays had been optimized utilizing the corresponding virus-like particles to realize limits of detection of 6.5 and eight.2 fg/mL for HEV-LPs and NoV-LPs, respectively. The SERS-based approach achieved a sign enhancement issue of as much as ∼108 as a result of mixed electromagnetic and chemical mechanisms of the employed dual-SERS substrate of MoO3-QDs/2D hexagonal boron nitride nanosheets.
The spotlight and validation of the developed SERS-based immunoassays was the detection of NoV in contaminated sufferers’ fecal specimen and medical HEV G7 subtype. Importantly, this method can be utilized to take care of the soundness of SERS nanotags and enhance their reliability in immunoassays.
Drilling into the Metabolomics to Improve Perception on Corn and Wheat Responses to Molybdenum Trioxide Nanoparticles
Metabolomics is an rising device to grasp the potential implications of nanotechnology, notably for agriculture. Though molybdenum (Mo) is a identified plant micronutrient, little is understood of its metabolic perturbations. Right here, corn and wheat seedlings had been uncovered to MoO3 nanoparticles (NPs) and the corresponding bioavailable Mo6+ ion at reasonable and extreme ranges by means of root exposures.
Physiologically, corn was extra delicate to Mo, which gathered as much as 3.63 occasions extra Mo than wheat. In distinction, metabolomics indicated 21 dysregulated metabolites in corn leaves and 53 in wheat leaves. 5 extra metabolomic pathways had been perturbed in wheat leaves in comparison with corn leaves. Along with the general metabolomics evaluation, we additionally analyzed particular person metabolite courses (e.g., amino acids, natural acids, and so forth.), yielding extra dysregulated metabolites in plant tissues: 7 for corn and seven for wheat.
Most of those had been amino acids in addition to some sugars. Further considerably dysregulated metabolites (e.g., asparagine, fructose, lowered glutathione, mannose) had been recognized in each corn and wheat, because of Mo NP publicity, by using particular person metabolite group evaluation. Focused metabolite evaluation of particular person teams is thus essential for locating extra important metabolites. We show the worth of metabolomics to check early stage plant responses to NP publicity.
Arsenic trioxide enhances the chemotherapeutic effectivity of cisplatin in cholangiocarcinoma cells through inhibiting the 14-3-3ε-mediated survival mechanism
Cholangiocarcinoma (CCA) is the second most frequent main liver carcinoma with excessive levels of malignancy and mortality. Chemotherapy performs a key function within the therapy of CCA, nonetheless, the low chemotherapeutic effectivity results in a bottleneck. So unraveling the potential mechanisms to boost the effectivity (lowered the dosage and enhanced the results of chemotherapy medication) and figuring out different therapeutic methods in CCA are urgently wanted.
Right here, we discovered that, in CCA cells, when cisplatin (CDDP) displayed anti-tumor results, it activated 14-3-3ε concurrently, which in flip shaped a survival mechanism through the phosphorylation of phosphatidylinositol 3-kinase/protein kinase B (PI-3K/Akt). Nonetheless, low concentrations of arsenic trioxide (ATO) may disrupt such survival mechanism and enhanced the effectivity. For the molecular mechanisms, ATO attenuated 14-3-3ε at each transcriptional and post-transcriptional (ubiquitination degradation) ranges.
Such repressive impact blocked the activation of PI-3K/Akt, and its downstream anti-apoptotic elements, B-cell lymphoma 2 (Bcl-2), and survivin. Collectively, our current research revealed that the synergistic results of ATO and CDDP could possibly be a novel strategy for enhancing the effectivity, which supplies an progressive therapeutic imaginative and prescient for the therapy of CCA.
Extreme Wernicke encephalopathy and acute pancreatitis because of all-trans-retinoic acid and arsenic trioxide throughout therapy of acute promyelocytic leukaemia: a case report
A 55-year-old lady developed acute promyelocytic leukaemia throughout therapy with all-trans-retinoic acid and arsenic trioxide. Initially, she introduced with signs of epigastric ache, vomiting, and nausea, and he or she developed acute pancreatitis. She was handled with parenteral dietary supplementation for 20 days. Nonetheless, the affected person continued to develop refractory hyponatraemia, hypotension, and apathy.
Lastly, the affected person was recognized with Wernicke encephalopathy (WE) utilizing head magnetic resonance imaging. The affected person underwent high-dose intravenous thiamine administration, and her signs had been alleviated. WE is a uncommon opposed occasion throughout acute pancreatitis remedy. Acute pancreatitis that’s attributable to all-trans-retinoic acid and arsenic trioxide is a uncommon complication of acute promyelocytic leukaemia throughout chemotherapy.
Additional research is important to enhance our comprehension of the danger elements for issues in sufferers with acute promyelocytic leukaemia, contemplating that the related issues had been probably attributable to a number of etiological elements.
Molybdenum trioxide 99.5%_x000D__x000D_ |
|||
M31150 | Pfaltz & Bauer | 100G | EUR 227.4 |
Molybdenum |
|||
23316-12 | NACALAI TESQUE | 25G | EUR 23.1 |
Molybdenum |
|||
M361000 | Toronto Research Chemicals | 10g | EUR 65 |
Description: 7439-98-7 |
Molybdenum trichloride 99.5% |
|||
M31145 | Pfaltz & Bauer | 1G | EUR 184.87 |
Molybdenum trisulfide dihydrate |
|||
M31160 | Pfaltz & Bauer | 5G | EUR 805.61 |
Antimony trioxide, Hi-AR™ |
|||
GRM6604-100G | EWC Diagnostics | 1 unit | EUR 10.5 |
Description: Antimony trioxide, Hi-AR™ |
Antimony trioxide, Hi-AR™ |
|||
GRM6604-500G | EWC Diagnostics | 1 unit | EUR 50.46 |
Description: Antimony trioxide, Hi-AR™ |
Molybdenum Dioxide |
|||
M30990 | Pfaltz & Bauer | 100G | EUR 200.55 |
Molybdenum disulfide |
|||
581228 | MedKoo Biosciences | 100.0g | EUR 240 |
Molybdenum disulfide |
|||
T19986-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Molybdenum disulfide |
Molybdenum disulfide |
|||
T19986-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Molybdenum disulfide |
Molybdenum disulfide |
|||
T19986-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Molybdenum disulfide |
Molybdenum disulfide |
|||
T19986-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Molybdenum disulfide |
Molybdenum disulfide |
|||
T19986-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Molybdenum disulfide |
Molybdenum disulphide |
|||
RM6087-100G | EWC Diagnostics | 1 unit | EUR 33.08 |
Description: Molybdenum disulphide |
Molybdenum disulphide |
|||
RM6087-500G | EWC Diagnostics | 1 unit | EUR 148.52 |
Description: Molybdenum disulphide |
Molybdenum(Ⅵ) Oxide |
|||
23322-22 | NACALAI TESQUE | 25G | EUR 14.35 |
Molybdenum(Ⅵ) Oxide |
|||
23322-35 | NACALAI TESQUE | 500G | EUR 193.55 |
Molybdenum boride, 99% |
|||
GX2434-50 | Glentham Life Sciences | 50 | EUR 451.4 |
Molybdenum boride, 99+% |
|||
GX5267-10 | Glentham Life Sciences | 10 | EUR 122.1 |
Molybdenum boride, 99+% |
|||
GX5267-50 | Glentham Life Sciences | 50 | EUR 301.3 |
Molybdenum boride, 98+% |
|||
GX5774-100 | Glentham Life Sciences | 100 | EUR 228.1 |
Molybdenum boride, 98+% |
|||
GX5774-25 | Glentham Life Sciences | 25 | EUR 111.5 |
Molybdenum powder 99.95% |
|||
M30900 | Pfaltz & Bauer | 25G | EUR 190.7 |
Molybdenum Foil0.05mm, 99.9+% |
|||
GX5354-100 | Glentham Life Sciences | 100 | EUR 205.4 |
Molybdenum Foil0.05mm, 99.9+% |
|||
GX5354-150 | Glentham Life Sciences | 150 | EUR 337.3 |
Molybdenum carbide 99.8% |
|||
M30950 | Pfaltz & Bauer | 5G | EUR 67.9 |
Molybdenum silicide, 99.5% |
|||
GX2864-100 | Glentham Life Sciences | 100 | EUR 146.2 |
Molybdenum silicide, 99.5% |
|||
GX2864-250 | Glentham Life Sciences | 250 | EUR 268.8 |
Molybdenum carbonyl 98% |
|||
M30960 | Pfaltz & Bauer | 5G | EUR 208.03 |
Molybdenum diboride 97% |
|||
M30980 | Pfaltz & Bauer | 1G | EUR 92.6 |
Molybdenum silicide 99.5% |
|||
M31125 | Pfaltz & Bauer | 100G | EUR 540.33 |
Molybdenum(V) Chloride |
|||
M489000 | Toronto Research Chemicals | 10g | EUR 138 |
Description: 10241-05-1 |
Molybdenum phthalocyanine |
|||
M31100 | Pfaltz & Bauer | 1G | EUR 403.04 |
Chromium trioxide, Hi-AR™/ACS |
|||
GRM1357-500G | EWC Diagnostics | 1 unit | EUR 14.82 |
Description: Chromium trioxide, Hi-AR™/ACS |
Molybdenum disulfide 92% |
|||
M31020 | Pfaltz & Bauer | 100G | EUR 136.2 |
Molybdenum metal powder |
|||
GRM3558-25G | EWC Diagnostics | 1 unit | EUR 69.38 |
Description: Molybdenum metal powder |
Molybdenum Foil 0.2mm, 99.95% |
|||
GX1246-100 | Glentham Life Sciences | 100 | EUR 164.5 |
Molybdenum Foil 0.3mm, 99.95% |
|||
GX1962-100 | Glentham Life Sciences | 100 | EUR 203.6 |
Molybdenum Foil 0.1mm, 99.95% |
|||
GX2552-100 | Glentham Life Sciences | 100 | EUR 132.6 |
Molybdenum(VI) oxide, 99.0% |
|||
GX6266-250 | Glentham Life Sciences | 250 | EUR 119.1 |
Molybdenum(VI) oxide, 99.0% |
|||
GX6266-500 | Glentham Life Sciences | 500 | EUR 192.2 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-1 | Glentham Life Sciences | 1 | EUR 355.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-100 | Glentham Life Sciences | 100 | EUR 99.7 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-100G | Glentham Life Sciences | 100 g | EUR 156 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-1KG | Glentham Life Sciences | 1 kg | EUR 466.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-250 | Glentham Life Sciences | 250 | EUR 151.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-250G | Glentham Life Sciences | 250 g | EUR 219.6 |
Molybdenum Foil 0.5mm, 99.95% |
|||
GX9163-100 | Glentham Life Sciences | 100 | EUR 231.3 |
Molybdenum Foil 1.0mm, 99.9+% |
|||
GX9760-100 | Glentham Life Sciences | 100 | EUR 309.6 |
Molybdenum Foil 1.0mm, 99.9+% |
|||
GX9760-150 | Glentham Life Sciences | 150 | EUR 313 |
Molybdenum(IV) oxide, 99+% |
|||
GX0932-100 | Glentham Life Sciences | 100 | EUR 208.6 |
Molybdenum(IV) oxide, 99+% |
|||
GX0932-25 | Glentham Life Sciences | 25 | EUR 93.4 |
Molybdenum disilicide 99.5% |
|||
M31010 | Pfaltz & Bauer | 50G | EUR 321.6 |
Molybdenum Sheet 2.5mm, 99.9+% |
|||
GX3862-100 | Glentham Life Sciences | 100 | EUR 301.3 |
Molybdenum Foil 0.15mm, 99.95% |
|||
GX4416-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Molybdenum Sheet 3mm, 99.9+% |
|||
GX6521-100 | Glentham Life Sciences | 100 | EUR 485.6 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-100 | Glentham Life Sciences | 100 | EUR 120.5 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-150 | Glentham Life Sciences | 150 | EUR 182.5 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-50 | Glentham Life Sciences | 50 | EUR 98 |
Molybdenum Sheet 2mm, 99.9+% |
|||
GX9338-100 | Glentham Life Sciences | 100 | EUR 264 |
Molybdenum Sheet 1.5mm, 99.9+% |
|||
GX9615-100 | Glentham Life Sciences | 100 | EUR 215.1 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-100 | Glentham Life Sciences | 100 | EUR 177.5 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-150 | Glentham Life Sciences | 150 | EUR 220.1 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-50 | Glentham Life Sciences | 50 | EUR 104 |
Molybdenum(II) carbide, 99.5+% |
|||
GX1923-100 | Glentham Life Sciences | 100 | EUR 129.6 |
Molybdenum(II) carbide, 99.5+% |
|||
GX1923-250 | Glentham Life Sciences | 250 | EUR 255.7 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-1 | Glentham Life Sciences | 1 | EUR 241.2 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-250 | Glentham Life Sciences | 250 | EUR 116.1 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-500 | Glentham Life Sciences | 500 | EUR 146.2 |
Molybdenum hexafluoride 99% |
|||
M31040 | Pfaltz & Bauer | 50G | EUR 3926.85 |
Molybdenum Standard Solution |
|||
37521-24 | NACALAI TESQUE | 100ML | EUR 21 |
Molybdenum cofactor sulfurase |
|||
AP84973 | SAB | 1mg | EUR 2640 |
Molybdenum cofactor sulfurase |
|||
AP85269 | SAB | 1mg | EUR 2640 |
Molybdenum cofactor sulfurase |
|||
AP85366 | SAB | 1mg | EUR 2640 |
ICP Std Molybdenum 1000ug/mL in H2O - 1L |
|||
PMO2C1L | Scientific Laboratory Supplies | 1L | EUR 693.27 |
ICP Std Molybdenum 10000ug/mL in H2O - 250ML |
|||
RPMO4B7 | Scientific Laboratory Supplies | 250ML | EUR 265.85 |
ICP Std Molybdenum 1000ug/mL in 1% HCl - 100ML |
|||
PMO2A11 | Scientific Laboratory Supplies | 100ML | EUR 151.29 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-100 | Glentham Life Sciences | 100 | EUR 114.5 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-250 | Glentham Life Sciences | 250 | EUR 160.5 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-500 | Glentham Life Sciences | 500 | EUR 269.6 |
Molybdenum Rod 20 mm diameter, 99.9+% |
|||
GX2933-100 | Glentham Life Sciences | 100 | EUR 303.1 |
Molybdenum Rod 20 mm diameter, 99.9+% |
|||
GX2933-500 | Glentham Life Sciences | 500 | EUR 1165.9 |
Molybdenum Rod 2.5 mm diameter, 99.9+% |
|||
GX3152-500 | Glentham Life Sciences | 500 | EUR 105.5 |
Molybdenum Rod 8.0 mm diameter, 99.9+% |
|||
GX3370-250 | Glentham Life Sciences | 250 | EUR 241.2 |
Molybdenum Rod 6.0 mm diameter, 99.9+% |
|||
GX4022-250 | Glentham Life Sciences | 250 | EUR 167.9 |
Molybdenum Rod 4.0 mm diameter, 99.9+% |
|||
GX5235-250 | Glentham Life Sciences | 250 | EUR 120.5 |
Molybdenum Rod 4.0 mm diameter, 99.9+% |
|||
GX5235-500 | Glentham Life Sciences | 500 | EUR 163 |
Molybdenum Rod 3.0 mm diameter, 99.9+% |
|||
GX6474-500 | Glentham Life Sciences | 500 | EUR 107 |
Molybdenum Rod 1 mm diameter, 99.95% |
|||
GX7974-1 | Glentham Life Sciences | 1 | EUR 105.5 |
Molybdenum Rod 2.0 mm diameter, 99.9+% |
|||
GX8666-1 | Glentham Life Sciences | 1 | EUR 164.5 |
Molybdenum Rod 2.0 mm diameter, 99.9+% |
|||
GX8666-500 | Glentham Life Sciences | 500 | EUR 102.4 |
Molybdenum Rod 10 mm diameter, 99.95% |
|||
GX8980-100 | Glentham Life Sciences | 100 | EUR 179.3 |
Molybdenum Rod 10 mm diameter, 99.95% |
|||
GX8980-250 | Glentham Life Sciences | 250 | EUR 332.3 |
Molybdenum Rod 1.5 mm diameter, 99.95% |
|||
GX9336-1 | Glentham Life Sciences | 1 | EUR 135.6 |
Molybdenum Rod 30 mm diameter, 99.9+% |
|||
GX9467-100 | Glentham Life Sciences | 100 | EUR 536.1 |
Molybdenum Rod 12 mm diameter, 99.9+% |
|||
GX0906-100 | Glentham Life Sciences | 100 | EUR 210.1 |
Molybdenum Wire 0.5 mm diameter, 99.95% |
|||
GX3073-100 | Glentham Life Sciences | 100 | EUR 382.9 |
Molybdenum Wire 0.5 mm diameter, 99.95% |
|||
GX3073-25 | Glentham Life Sciences | 25 | EUR 147.6 |
Molybdenum Powder, 2-5 micron, 99.95+% |
|||
GX4223-100 | Glentham Life Sciences | 100 | EUR 99.4 |
Molybdenum Powder, 2-5 micron, 99.95+% |
|||
GX4223-500 | Glentham Life Sciences | 500 | EUR 277.1 |
Molybdenum Wire 1.0 mm diameter, 99.95% |
|||
GX4703-25 | Glentham Life Sciences | 25 | EUR 290 |
Molybdenum Wire 1.0 mm diameter, 99.95% |
|||
GX4703-5 | Glentham Life Sciences | 5 | EUR 119.1 |
Molybdenum Wire 0.3 mm diameter, 99.95% |
|||
GX7025-100 | Glentham Life Sciences | 100 | EUR 228.1 |
Molybdenum Wire 0.3 mm diameter, 99.95% |
|||
GX7025-25 | Glentham Life Sciences | 25 | EUR 111.5 |
Molybdenum Wire 0.25 mm diameter, 99.95% |
|||
GX7146-100 | Glentham Life Sciences | 100 | EUR 184.1 |
Molybdenum Wire 0.25 mm diameter, 99.95% |
|||
GX7146-25 | Glentham Life Sciences | 25 | EUR 96.4 |
Molybdenum Wire 0.7 mm diameter, 99.95% |
|||
GX7237-10 | Glentham Life Sciences | 10 | EUR 105.5 |
Molybdenum Wire 0.7 mm diameter, 99.95% |
|||
GX7237-25 | Glentham Life Sciences | 25 | EUR 177.5 |
Molybdenum Wire 0.1 mm diameter, 99.95% |
|||
GX7396-100 | Glentham Life Sciences | 100 | EUR 125.1 |
Molybdenum Wire 0.1 mm diameter, 99.95% |
|||
GX7396-50 | Glentham Life Sciences | 50 | EUR 90.4 |
Molybdenum Wire 2.0 mm diameter, 99.95% |
|||
GX0175-1 | Glentham Life Sciences | 1 | EUR 126.5 |
Molybdenum Wire 2.0 mm diameter, 99.95% |
|||
GX0175-5 | Glentham Life Sciences | 5 | EUR 314.4 |
Molybdenum Wire 1.5 mm diameter, 99.95% |
|||
GX0574-1 | Glentham Life Sciences | 1 | EUR 99.4 |
Molybdenum Wire 1.5 mm diameter, 99.95% |
|||
GX0574-5 | Glentham Life Sciences | 5 | EUR 224.9 |
ICP Std Molybdenum 1000ug/mL in 2% NH4OH - 250ML |
|||
PMO2B7 | Scientific Laboratory Supplies | 250ML | EUR 240.3 |
ICP Std Molybdenum 1000ug/mL in 2% NH4OH - 500ML |
|||
PMO2C7 | Scientific Laboratory Supplies | 500ML | EUR 434.76 |
ICP Std Molybdenum 10000ug/mL in 2% NH4OH - 100ML |
|||
PMO4A7 | Scientific Laboratory Supplies | 100ML | EUR 259.98 |
ICP Std Molybdenum 10000ug/mL in 3.5% NH4OH - 500ML |
|||
PMO4B4-500ML | Scientific Laboratory Supplies | 500ML | EUR 1038.44 |
Molybdenum Pellets 6 x 12 mm, 99.9+% |
|||
GX2699-100 | Glentham Life Sciences | 100 | EUR 198.7 |
Molybdenum Pellets 6 x 12 mm, 99.9+% |
|||
GX2699-25 | Glentham Life Sciences | 25 | EUR 99.4 |
Molybdenum Oxytetrachloride 97% _x000D_ |
|||
M31060 | Pfaltz & Bauer | 10G | EUR 277.73 |
Molybdenum Powder max. 100 micron, 99.9% |
|||
GX3538-100 | Glentham Life Sciences | 100 | EUR 123.5 |
Molybdenum Powder max. 100 micron, 99.9% |
|||
GX3538-500 | Glentham Life Sciences | 500 | EUR 303.1 |
ICP Std Molybdenum 100ug/mL in 2% NH4OH - 100ML |
|||
PMO1A7 | Scientific Laboratory Supplies | 100ML | EUR 265.85 |
ICP Std Molybdenum 100ug/mL in 2% NH4OH - 500ML |
|||
PMO1C3 | Scientific Laboratory Supplies | 500ML | EUR 409.8 |
molybdenum cofactor sulfurase Antibody |
|||
E300911 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
Molybdenum(IV) disulfide Nanopowder, 99 % |
|||
GX4987-10 | Glentham Life Sciences | 10 | EUR 311.3 |
Molybdenum(IV) disulfide Nanopowder, 99 % |
|||
GX4987-25 | Glentham Life Sciences | 25 | EUR 593.2 |
AAS Molybdenum Std 1000ppm in H2O - 500ML |
|||
AAMOH | Scientific Laboratory Supplies | 500ML | EUR 120.15 |
AAS Molybdenum Std 10000ppm in H2O - 500ML |
|||
AAMOM | Scientific Laboratory Supplies | 500ML | EUR 380.7 |
Molybdenum Foil 0.1 mm, plane, shiny, 99.95% |
|||
GX4593-100 | Glentham Life Sciences | 100 | EUR 180.9 |
ICP Std Molybdenum 1000ug/mL in 2-5% HNO3 tr. HF - 100ML |
|||
PMO2A10 | Scientific Laboratory Supplies | 100ML | EUR 277.6 |
Molybdenum Cofactor Synthesis 2 Protein |
|||
20-abx263321 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 Protein |
|||
abx263321-10mg | Abbexa | 10 mg | EUR 325 |
Molybdenum Cofactor Synthesis 2 Protein |
|||
abx263321-25mg | Abbexa | 25 mg | EUR 1600 |
Molybdenum Cofactor Synthesis 2 Protein |
|||
abx263321-5mg | Abbexa | 5 mg | EUR 225 |
Arsenic trioxide |
|||
A35645 | Pfaltz & Bauer | 500G | EUR 159 |
ICP Standard Molybdenum H2O 1000ug/ml - 100ML |
|||
PMO2A7 | Scientific Laboratory Supplies | 100ML | EUR 148.5 |
Chromium trioxide |
|||
GRM1057-1KG | EWC Diagnostics | 1 unit | EUR 21.58 |
Description: Chromium trioxide |
Chromium trioxide |
|||
GRM1057-500G | EWC Diagnostics | 1 unit | EUR 12.03 |
Description: Chromium trioxide |
Vanadium trioxide |
|||
V00590 | Pfaltz & Bauer | 25G | EUR 217.95 |
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
20-abx113870 | Abbexa |
|
|
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
abx235263-100ug | Abbexa | 100 ug | EUR 577.2 |
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
abx113870-100l | Abbexa | 100 µl | EUR 612.5 |
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
abx235263-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum pentachloride 99% metals basis_x000D__x000D_ |
|||
M31080 | Pfaltz & Bauer | 10G | EUR 283 |
Human Molybdenum cofactor sulfurase ELISA Kit |
|||
EK3232 | SAB | 96 tests | EUR 636 |
(untagged)-Human molybdenum cofactor biosynthesis protein A and molybdenum cofactor biosynthesis protein C mRNA, complete cds |
|||
SC313241 | Origene Technologies GmbH | 10 µg | Ask for price |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx131326 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx131327 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx135733 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx113871 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx005887 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx036894-100ug | Abbexa | 100 ug | EUR 469.2 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx037731-100ug | Abbexa | 100 ug | EUR 469.2 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx025653-400ul | Abbexa | 400 ul | EUR 627.6 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx025653-80l | Abbexa | 80 µl | EUR 343.2 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx028710-400ul | Abbexa | 400 ul | EUR 627.6 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx028710-80l | Abbexa | 80 µl | EUR 343.2 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx235264-100ug | Abbexa | 100 ug | EUR 577.2 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx304514 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx321401 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx321402 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx321947 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx322547 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx113871-100l | Abbexa | 100 µl | EUR 612.5 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx304514-100g | Abbexa | 100 µg | EUR 362.5 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx304514-20g | Abbexa | 20 µg | EUR 162.5 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx304514-50g | Abbexa | 50 µg | EUR 250 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx036894-96tests | Abbexa | 96 tests | EUR 337.5 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx037731-96tests | Abbexa | 96 tests | EUR 337.5 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx025653-400l | Abbexa | 400 µl | EUR 518.75 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx028710-400l | Abbexa | 400 µl | EUR 518.75 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx235264-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx135733-100tests | Abbexa | 100 tests | EUR 175 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx131326-05mg | Abbexa | 0.5 mg | EUR 275 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx131327-05mg | Abbexa | 0.5 mg | EUR 275 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx321401-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx321401-50g | Abbexa | 50 µg | EUR 250 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx321402-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx321402-50g | Abbexa | 50 µg | EUR 250 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx321947-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx321947-50g | Abbexa | 50 µg | EUR 250 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx322547-100g | Abbexa | 100 µg | EUR 350 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx322547-50g | Abbexa | 50 µg | EUR 250 |
di-Boron Trioxide |
|||
05219-65 | NACALAI TESQUE | 500G | EUR 16.8 |
di-Boron Trioxide |
|||
05220-12 | NACALAI TESQUE | 25G | EUR 10.15 |
di-Boron Trioxide |
|||
05220-25 | NACALAI TESQUE | 500G | EUR 34.3 |
Bismuth trioxide 99% |
|||
B15890 | Pfaltz & Bauer | 100G | EUR 254 |
Rhenium trioxide 99.9% |
|||
R01120 | Pfaltz & Bauer | 1G | EUR 441.89 |
di-Boron trioxide |
|||
RM6690-250G | EWC Diagnostics | 1 unit | EUR 51.89 |
Description: di-Boron trioxide |
Molybdenum Pellets‚6.35 x 6.35 mm, vacuum melted, 99.98% |
|||
GX9003-100 | Glentham Life Sciences | 100 | EUR 293.3 |
Molybdenum Pellets‚6.35 x 6.35 mm, vacuum melted, 99.98% |
|||
GX9003-25 | Glentham Life Sciences | 25 | EUR 119.1 |
Quantifoil™ R 1/4 (SiO2) on 200 molybdenum mesh |
|||
X-505-MO200 | Jena Bioscience GmbH | 100pcs. | EUR 1906 |
Chromium trioxide 99% |
|||
C21915 | Pfaltz & Bauer | 25G | EUR 129.65 |
×
A greater understanding of those threat elements could assist to enhance the prognosis of sufferers with acute promyelocytic leukaemia at an early stage.
Tags: buy plasmid crispr plasmid dna center of america dna function dna hrblock login dna project dna questions answers dna sentinel login dna stands for dna strand dna synthesis dna testing kits dna tests fitc ph fitcard fitcard login fitch apparel fitch ratings careers fitchburg fitchburg blackboard fitchburg landfill fitchburg ma fitchburg mass fitchburg plumbing fitchburg sentinel fitchburg state fitchburg state college fitchburg state university fitchburg state university jobs fitchburg wi fitchef fitchett funeral home fitchette fitcord x-over resistance login luciferase plasmid